Brain-derived neurotrophic factor serum concentrations are increased in drug-naïve schizophrenic patients with chronic cannabis abuse and multiple substance abuse

Neuroscience Letters

Volumn 371, Issue 1, 2004, Pages 79-83

  Jockers Scherübl, Maria C ^a   Danker Hopfe, Heidi ^a   Mahlberg, Richard ^a   Selig, Franziska ^a   Rentzsch, Johannes ^a   Schürer, Falk ^a   Lang, Undine E ^a   Hellweg, Rainer ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

BDNF; Brain derived neurotrophic factor; Cannabis; Drug na ve; Multiple substance abuse; Neurodevelopment; Neurotrophins; Schizophrenia

Indexed keywords

CANNABIS;

ADULT; ARTICLE; BRAIN INJURY; CANNABIS ADDICTION; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG SENSITIVITY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE DRUG ABUSE; NERVE CELL DIFFERENTIATION; NEUROTOXICITY; ONSET AGE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; AMPHETAMINE-RELATED DISORDERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CANNABIS; COCAINE-RELATED DISORDERS; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; SCHIZOPHRENIA;

EID: 6944225745     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.08.045     Document Type: Article

References (19)

1. L. Aloe, A. Ianitelli, F. Angelucci, G. Bersani, and M. Fiore Studies in animal models and humans suggesting a role of nerve growth factor in schizophrenia-like disorders Behav. Pharmacol. 11 2000 235 242
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders fourth ed. 1994 American Psychiatric Press Washington, DC
3. S. Andreasson, P. Allebeck, A. Engstrom, and U. Rydberg Cannabis and schizophrenia. A longitudinal study of Swedish conscripts Lancet 2 1987 1483 1485
4. A. Chiaretti, M. Piastra, G. Polidori, C. Di Rocco, E. Caresta, A. Antonelli, T. Amendola, and L. Aloe Correlation between neurotrophic factor expression and outcome of children with severe traumatic brain injury Intensive Care Med. 29 2003 1329 1338
5. H. Ehrenreich, T. Rinn, H.J. Kunert, M.R. Moeller, W. Poser, L. Schilling, G. Gigerenzer, and M.R. Hoehe Specific attentional dysfunction in adults following early start of cannabis use Psychopharmacology (Berl.) 142 1999 295 301
6. S.M. Gold, K.H. Schulz, S. Hartmann, M. Mladek, U.E. Lang, R. Hellweg, R. Reer, K.M. Braumann, and C. Heesen Basal levels and reactivity of nerve growth factor and brain-derived neurotrophic factor to standardized acute exercise in multiple sclerosis and controls J. Neuroimmunol. 138 2003 99 105
7. R. Hellweg, C.A.F. von Arnim, M. Büchner, R. Huber, and M.W. Riepe Neuroprotection and neuronal dysfunction upon repetitive inhibition of oxidative phosphorylation Exp. Neurol. 183 2003 346 354
8. L. Iversen Cannabis and the brain Brain 126 2003 1252 1270
9. M.C. Jockers-Scherübl, U. Matthies, H. Danker-Hopfe, U.E. Lang, R. Mahlberg, and R. Hellweg Chronic cannabis abuse raises nerve growth factor serum concentrations in drug-naive schizophrenic patients J. Psychopharmacol. 17 2003 439 445
10. H. Kang, and E.M. Schuman Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus Science 267 1995 1658 1662
11. F. Karege, M. Schwald, and M. Cisse Postnatal development profile of brain-derived neurotrophic factor in rat brain and platelets Neurosci. Lett. 328 2002 261 264
12. U.E. Lang, M.C. Jockers-Scherübl, and R. Hellweg State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitations J. Neural Transm. 111 2004 387 411
13. U.E. Lang, J. Gallinat, S. Kuhn, M.C. Jockers-Scherübl, and R. Hellweg Nerve growth factor and smoking cessation Am. J. Psychiatry 159 2002 674 675
14. S. Marenco, and D.R. Weinberger The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave Dev. Psychopathol. 12 2000 501 527
15. W. Pan, W.A. Banks, M.B. Fasold, J. Bluth, and A.J. Kastin Transport of brain-derived neurotrophic factor across the blood-brain barrier Neuropharmacology 37 1998 1553 1561
16. E. Shimizu, K. Hashimoto, H. Watanabe, N. Komatsu, N. Okamura, K. Koike, N. Shinoda, M. Nakazato, C. Kumakiri, S. Okada, and M. Iyo Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls Neurosci. Lett. 351 2003 111 114
17. M. Takahashi, O. Shirakawa, K. Toyooka, N. Kitamura, T. Hashimoto, K. Maeda, S. Koizumi, K. Wakabayashi, H. Takahashi, T. Someya, and H. Nawa Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients Mol. Psychiatry 5 2000 293 300
18. K. Toyooka, K. Asama, Y. Watanabe, T. Muratake, M. Takahashi, T. Someya, and H. Nawa Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients Psychiatry Res. 110 2002 249 257
19. D.R. Weinberger Cell biology of the hippocampal formation in schizophrenia Biol. Psychiatry 45 1999 395 402